.jpg)
1 hour ago
3
Article content
RESEARCH TRIANGLE PARK, N.C., June 10, 2026 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Detailed results of the vote for the election of directors are set out below:
Article content
Article content
| Name of Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld | ||
| Dr. Khalid Islam | 13,858,131 | 97.84 | % | 304,760 | 2.15 | % |
| Mr. Chris A. Rallis | 13,808,792 | 97.49 | % | 354,099 | 2.50 | % |
| Mr. Marco Brughera | 13,807,501 | 97.49 | % | 355,390 | 2.50 | % |
| Dr. Jodi Cook | 13,259,894 | 93.62 | % | 902,997 | 6.37 | % |
| Mr. Jeff Hackman | 13,495,309 | 95.28 | % | 667,582 | 4.71 | % |
Article content
Article content
Shareholders voted 99.64% in favor of appointing Haskell & White LLP as auditors and authorizing the directors to fix the auditor remuneration, 85.50% in favor of the compensation paid to the Company’s named executive officers, and 91.27% (88.01% after subtracting shares held by insiders eligible to participate in the Company’s 2020 Equity Incentive Plan) in favor of certain amendment to the Company’s 2020 Equity Incentive Plan.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
The Company has relied on the exemption set forth in Section 602.1 of the TSX Company Manual, which provides that the TSX will not apply its standards to certain transactions involving eligible interlisted issuers on a recognized exchange, such as Nasdaq, in the approval of the amendments to its 2020 Equity Incentive Plan.
Article content
For further information, please contact:
Article content
Robert Andrade
Chief Financial Officer
Fennec Pharmaceuticals Inc.
Tel: 919-246-5299
Article content
Article content
Article content
Article content
Article content
Article content
English (US)